#1
ٰŷ OTC Ӿ
2 vs. 3 ٸ?
#2
汸Ӿ Ʈΰհ ΰԽƾ , ΰԽƾ п 1~4 մϴ.
1 㰡 ǰ , Ϻ ȣ ǰ, 4 Ǿǰ зǰ ־ ౹ ִ OTC Ӿ 2 3 ϴ.
#3
3 Ӿ 2 ΰԽƾ ΰԽ ȿ ϸ鼭 ȵΰ ۿ ҽŰ ߵǾϴ. 3 Ӿ 2뺸 ȵΰ ۿ ҵǾ, ֽϴ.
#4
汸Ӿ ִ ̻ʴ ұĢ ֽϴ.
2 븣ԽƮ 3 ҰԽƮ
ƼҿƮ+븣ԽƮ ӽ÷ ұĢ ϰ ϴ.
#5
() ù ° ֱ , Ʈΰ Է ν Ʈΰ ߵ ̻(, , ) ҵǾϴ.
#6
Ϻ 3 ΰԽƾ Ӿ VTE() 2 ΰԽƾ Ͽ ߴٴ õǾϴ.
ٸ ̷ 赵 ʾҽϴ.
"ΰԽƾ VTE 赵 Ȯ ִ ü RCT , ġ Ƿ Ӿ ǰ Ͽ Ǵؾ մϴ١
#7
Ӿ VTE ӽ , VTE ϴ.
#8
㰡 汸Ӿ 35 ̻ ݱϰ ֽϴ.
ȯ̳ ۿ ־, ɼ ū ݵ Ȯ ʿմϴ.
#9
Ӿ ٸ Բ , ٸ Ӿ ȣۿ ȿ ų ۿ ֽϴ.
: ̾Ʈ ô зǴ ǶƮ Բ óǴ 찡 ִµ ̷ 汸 Ӿ ȿ ҽų ֽϴ.
#10
Ե õ , ӽ÷ ϴ Ӿ ϴ.
Һ Ӿ Բ ȯ Ȱ ŷ, Ȯϰ, ùٸ Ӿ ּ!
#11
1. The Faculty of Sexual & Reproductive Healthcare Guideline. Combined Hormonal Contraception. 2019.
2. Speroff L, Marc AF. Clinical Gynecologic Endocrinology and Infertility, 8th Ed. LWW. 2010. P.966-7.
3. Guillebaud J, MacGregor A. Contraception: Your Questions Answered. 7th Ed. Elsevier. 2017.
4. ǰǾǰó, Ŵ(ǻ), 2016. Avaliable at: https://nedrug.mfds.go.kr/pbp/CCBFC03/getItem?totalPages=5&limit=12&page=2&&tchmtrId=SU201911240035#SU2019112400355 [Accessed May 11, 2022]
5. Lammers P et al. Acta Obstet Gynecol Scand 1991;70:497-500
6. Winkler UH, et al. Contraception 2005;69:469-76
7. ǰǾǰó Ǿǰý, ӽ÷Т 㰡, Available at: https://nedrug.mfds.go.kr/pbp/CCBBB01/getItemDetail?itemSeq=200009522 [Accessed May 11, 2022]
8. The Society of Obstetricians and Gynaecologists of Canada. Position Statement. Hormonal contraception and risk of VTE. 2013.
9. Lawrie TA et al. Cochrane Database Syst Rev. 2011 May 11;(5):CD004861.
10. The American College of Obstetricians and Gynecologists. Committee Opinion. Risk of VTE among users of Drospirenone-containing OC pills. 2012
11. World Health Organization(WHO). Medical eligibility criteria for contraceptive use. 5th Ed. 2015